Premature Neonatal Articles & Analysis
4 news found
“At Bayer, we recognize that families with premature babies with retinopathy of prematurity are waiting for new effective and well tolerated treatment options to spare them from significant visual impairment and even blindness,” said Dr. ...
ByBayer AG
About Apnea of Prematurity Apnea of Prematurity (AoP) is a developmental disorder attributed to immaturity of the pulmonary system characterized by either cessation of breathing for more than twenty seconds or cessation of breathing which lasts less than twenty seconds but is accompanied by either bradycardia or hypoxemia. Apnea of Prematurity ...
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions, announced today that the Food and Drug Administration (FDA) has granted it's lead compound, ENA-001, rare pediatric disease designation for the treatment of Apnea of Prematurity. Enalare is planning to develop this ...
Products from Intus Biosciences demonstrated high-resolution tracking of specific bacterial strains in a recent microbiome study, the results of which are being applied to better understand how pathogens and commensals become established in premature infants in neonatal intensive care units (NICU), with the goal of improving outcomes for ...